Want to see IN:NATCOPHARM full AI Analyst Report?
NATCO Pharma Limited (NATCOPHARM) Revenue
NATCO Pharma Limited Revenue
NATCO Pharma Limited had a revenue of 7.35B in the quarter ending Jun 30, 2026, with -0.53%. This bring the company's revenue in the last twelve months to 34.85B, Decreased 14.56%. In the fiscal year ending Mar 31, 2026, NATCO Pharma Limited had annual revenue of 40.78B with -7.98% growth.
- Revenue (ttm)
- 34.85B
- Revenue Growth
- -20.73%
- P/S Ratio
- 3.76
- Revenue/Employee
- INR 9,199,865
- Employees
- 4,433
- Market Cap
- INR 153.50B
Revenue Chart
NATCO Pharma Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 40.78B | -3.54B | -7.98% |
| Mar 31, 2025 | 44.32B | 4.30B | 10.74% |
| Mar 31, 2024 | 40.02B | 12.94B | 47.76% |
| Mar 31, 2023 | 27.09B | 7.62B | 39.17% |
| Mar 31, 2022 | 19.46B | -1.10B | -5.35% |
| Mar 31, 2021 | 20.56B | 1.41B | 7.37% |
| Mar 31, 2020 | 19.15B | -1.79B | -8.57% |
| Mar 31, 2019 | 20.95B | -903.00M | -4.13% |
| Mar 31, 2018 | 21.85B | 1.65B | 8.15% |
| Mar 31, 2017 | 20.20B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:NATCOPHARM | 34.85B |
| IN:APLLTD | 77.84B |
| IN:GRANULES | 56.18B |
| IN:STAR | 48.59B |
| IN:WOCKPHARMA | 35.64B |